Dr. Christopher Smith, D.O

NPI: 1366681892
Total Payments
$946.80
2024 Payments
$137.98
Companies
12
Transactions
43

Payment Breakdown by Category

Food & Beverage$946.80 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $946.80 43 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $419.14 13 $0 (2024)
Janssen Pharmaceuticals, Inc $155.53 10 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $83.08 4 $0 (2021)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $55.69 3 $0 (2019)
Eisai Inc. $45.99 2 $0 (2024)
Novo Nordisk Inc $43.71 3 $0 (2024)
Mission Pharmacal Company $41.58 3 $0 (2020)
Dexcom, Inc. $26.71 1 $0 (2024)
SHIELD THERAPEUTICS INC $20.07 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $19.05 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $137.98 6 AstraZeneca Pharmaceuticals LP ($52.29)
2023 $17.87 1 AstraZeneca Pharmaceuticals LP ($17.87)
2022 $101.60 1 AstraZeneca Pharmaceuticals LP ($101.60)
2021 $71.33 4 Novo Nordisk Inc ($29.59)
2020 $152.31 8 AstraZeneca Pharmaceuticals LP ($62.93)
2019 $71.70 4 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($24.23)
2018 $100.17 7 Janssen Pharmaceuticals, Inc ($49.66)
2017 $293.84 12 AstraZeneca Pharmaceuticals LP ($184.45)

All Payment Transactions

43 individual payment records from CMS Open Payments — Page 2 of 2

Date Company Product Nature Form Amount Type
09/10/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $11.45 General
Category: Cardiovascular & Metabolism
08/20/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $16.15 General
Category: GASTROENTEROLOGY
07/02/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $12.98 General
Category: Cardiovascular & Metabolism
06/14/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $12.25 General
Category: Cardiovascular & Metabolism
04/23/2018 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $19.05 General
Category: Cardiovascular
04/18/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $12.98 General
Category: Cardiovascular & Metabolism
10/20/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.84 General
Category: Cardiovascular & Metabolism
08/30/2017 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular and Metabolism
08/09/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug) Food and Beverage In-kind items and services $15.17 General
Category: Cardiovascular & Metabolism
07/10/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.90 General
Category: Cardiovascular and Metabolism
06/28/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.69 General
Category: Cardiovascular and Metabolism
05/04/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $16.99 General
Category: Cardiovascular and Metabolism
04/25/2017 Mission Pharmacal Company Uribel (Drug) Food and Beverage In-kind items and services $10.69 General
Category: Analgesic, antispasmodic & antiseptic (urinary)
04/21/2017 Janssen Pharmaceuticals, Inc INVOKANA (Drug), INVOKAMET Food and Beverage In-kind items and services $21.58 General
Category: Cardiovascular & Metabolism
04/05/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.88 General
Category: Cardiovascular and Metabolism
04/05/2017 Mission Pharmacal Company Uribel (Drug) Food and Beverage In-kind items and services $10.95 General
Category: Analgesic, antispasmodic & antiseptic (urinary)
02/24/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.39 General
Category: Cardiovascular & Metabolism
01/12/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $15.77 General
Category: Cardiovascular & Metabolism

About Dr. Christopher Smith, D.O

Dr. Christopher Smith, D.O is a Dermatology healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1366681892.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Smith, D.O has received a total of $946.80 in payments from pharmaceutical and medical device companies, with $137.98 received in 2024. These payments were reported across 43 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($946.80).

Practice Information

  • Specialty Dermatology
  • Other Specialties Family Medicine, Family Medicine
  • Location Lauderhill, FL
  • Active Since 02/06/2009
  • Last Updated 11/28/2024
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1366681892

Products in Payments

  • FARXIGA (Drug) $192.55
  • BYDUREON (Drug) $124.99
  • ANDEXXA (Biological) $101.60
  • XARELTO (Drug) $100.66
  • JARDIANCE (Drug) $83.08
  • XIFAXAN (Drug) $55.69
  • INVOKANA (Drug) $54.87
  • RYBELSUS (Drug) $29.59
  • Dexcom G6 Transmitter (Medical Supply) $26.71
  • Leqembi (Drug) $24.79
  • Uribel (Drug) $21.64
  • Aduhelm (Drug) $21.20
  • ACCRUFER (Drug) $20.07
  • Ferralet 90 (Drug) $19.94
  • ELIQUIS (Drug) $19.05
  • JANUVIA (Drug) $19.02
  • ImmunoCAP (Device) $17.23
  • Ozempic (Drug) $14.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.